BioStem Technologies Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	57	64	230	95	36	10
Market Cap Growth	-70.06%	-72.22%	142.79%	161.02%	267.00%	-88.46%
Enterprise Value	46	40	220	101	40	11
Last Close Price	3.21	3.81	13.84	5.86	2.99	1.04
PE Ratio	-	-	7.43	-	-	-
Forward PE	-	18.14	6.85	8.62	23.44	-
PS Ratio	1.51	1.35	3.31	5.69	5.29	2.28
PB Ratio	1.79	1.64	5.76	-70.60	-9.21	-1.71
P/TBV Ratio	6.70	1.65	5.83	-	-	-
P/FCF Ratio	30.71	9.71	9.59	-	606.05	-
P/OCF Ratio	11.29	6.44	9.42	-	119.78	-
EV/Sales Ratio	1.23	0.85	3.16	6.04	5.87	2.53
EV/EBITDA Ratio	-	-	7.03	-	-	-
EV/EBIT Ratio	-	-	7.08	-	-	-
EV/FCF Ratio	25.08	6.11	9.16	-	672.38	-
Debt / Equity Ratio	0.10	0.09	0.11	-3.55	-1.32	-0.84
Debt / EBITDA Ratio	-	-	0.14	-	-	-
Debt / FCF Ratio	1.77	0.51	0.18	-	86.82	-
Net Debt / Equity Ratio	-0.33	-0.67	-0.46	-3.37	-1.12	-0.79
Net Debt / EBITDA Ratio	0.74	55.82	-0.59	-0.66	-0.99	-3.44
Net Debt / FCF Ratio	-5.63	-3.98	-0.77	-1.26	73.95	-29.89
Asset Turnover	0.37	0.88	1.91	1.85	2.24	-
Inventory Turnover	1.41	1.30	11.07	2.39	2.69	-
Quick Ratio	0.86	3.66	2.56	0.74	0.13	0.10
Current Ratio	1.14	4.12	2.89	0.81	0.24	0.14
Return on Equity (ROE)	-48.64%	-16.63%	160.46%	-	-	-
Return on Assets (ROA)	-9.06%	-0.80%	53.38%	-48.94%	-95.34%	-
Return on Capital Employed (ROCE)	-46.40%	-1.80%	77.10%	665.50%	163.60%	41.50%
Earnings Yield	-33.94%	-10.28%	13.47%	-8.94%	-19.78%	-14.59%
FCF Yield	3.26%	10.29%	10.43%	-3.80%	0.17%	-1.54%
Buyback Yield / Dilution	28.42%	22.90%	-58.30%	-20.18%	2.40%	-130.37%